Chemotherapeutic drugs induce oxidative stress associated with DNA repair and metabolism modulation.
Chemotherapeutic drugs induce oxidative stress associated with DNA repair and metabolism modulation.
复制标题
DOI:
10.1016/j.lfs.2021.120242
复制
发表时间:
2021-12
期刊:
影响因子:
6.1
通讯作者:
Yujie Zhang;Chunyang Ding;Wenkang Zhu;Xinyu Li;Techang Chen;Qingxi Liu;Sa Zhou;Tong-Cun Zhang-Tong-Cu
中科院分区:
文献类型:
--
作者:
Yujie Zhang;Chunyang Ding;Wenkang Zhu;Xinyu Li;Techang Chen;Qingxi Liu;Sa Zhou;Tong-Cun Zhang-Tong-Cu
Bulky DNA damage inducing chemotherapeutic cancer drugs such as cisplatin (CIS) and doxorubicin (DOX) are commonly used in the treatment of a variety of cancers. However, they often cause multi-organ toxicity, and the mechanisms underlying are not clear. Using cellular model, the present study showed that persistent endogenous reactive oxygen species (ROS) were stimulated after a single dose short treatment with CIS and DOX. ROS level correlated with the formation of DNA double-strand breaks (DSBs). Knockdown BRCA1, a key player involved in homologous recombination (HR), enhanced ROS accumulation. Whereas knockdown DNA-PKcs and overexpress BRCA1 to inhibit nonhomologous end-joining (NHEJ) repair pathway and restore HR can partially suppress ROS levels. These data indicated that ROS production is associated with DSB formation and repair which is likely a downstream event of DNA repair. Further studies showed that knockdown DNA repair regulators PP2A but not ATM, could partially reduce ROS too. The induction of ROS affected the level of proinflammatory cytokines interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Collectively, the present study reveals that DNA repair associated metabolism change and oxidative stress may be a direct cause of the severe side effects associated with genotoxic chemotherapy cancer drugs.